Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tournilhac, Olivier (VerfasserIn) , Altmann, Bettina (VerfasserIn) , Friedrichs, Birte (VerfasserIn) , Bouabdallah, Kamal (VerfasserIn) , Leclerc, Mathieu (VerfasserIn) , Cartron, Guillaume (VerfasserIn) , Turlure, Pascal (VerfasserIn) , Reimer, Peter (VerfasserIn) , Wagner-Drouet, Eva (VerfasserIn) , Sanhes, Laurence (VerfasserIn) , Houot, Roch (VerfasserIn) , Roussel, Murielle (VerfasserIn) , Kroschinsky, Frank (VerfasserIn) , Dreger, Peter (VerfasserIn) , Viardot, Andreas (VerfasserIn) , de Leval, Laurence (VerfasserIn) , Rosenwald, Andreas (VerfasserIn) , Gaulard, Philippe (VerfasserIn) , Wulf, Gerald (VerfasserIn) , Villate, Alban (VerfasserIn) , Latiere, Christelle (VerfasserIn) , Elmaagacli, Ahmet (VerfasserIn) , Glass, Bertram (VerfasserIn) , Poeschel, Viola (VerfasserIn) , Damaj, Gandhi (VerfasserIn) , Sibon, David (VerfasserIn) , Durot, Eric (VerfasserIn) , Bilger, Karin (VerfasserIn) , Banos, Anne (VerfasserIn) , Haenel, Mathias (VerfasserIn) , Dreyling, Martin (VerfasserIn) , Keller, Ulrich (VerfasserIn) , Tiab, Mourad (VerfasserIn) , Drenou, Bernard (VerfasserIn) , Cornillon, Jérome (VerfasserIn) , Nguyen, Stéphanie (VerfasserIn) , Robin, Marie (VerfasserIn) , Nickelsen, Maike (VerfasserIn) , Trümper, Lorenz (VerfasserIn) , Lenz, Georg (VerfasserIn) , Ziepert, Marita (VerfasserIn) , Schmitz, Norbert (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [2024]
In: Journal of clinical oncology
Year: 2024, Jahrgang: 42, Heft: 32, Pages: 3788-3794
ISSN:1527-7755
DOI:10.1200/JCO.24.00554
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.24.00554
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/JCO.24.00554
Volltext
Verfasserangaben:Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Guillaume Cartron, Pascal Turlure, Peter Reimer, Eva Wagner-Drouet, Laurence Sanhes, Roch Houot, Murielle Roussel, Frank Kroschinsky, Peter Dreger, Andreas Viardot, Laurence de Leval, Andreas Rosenwald, Philippe Gaulard, Gerald Wulf, Alban Villate, Christelle Latiere, Ahmet Elmaagacli, Bertram Glass, Viola Poeschel, Gandhi Damaj, David Sibon, Eric Durot, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Ulrich Keller, Mourad Tiab, Bernard Drenou, Jérome Cornillon, Stéphanie Nguyen, Marie Robin, Maike Nickelsen, Lorenz Trümper, Georg Lenz, Marita Ziepert, and Norbert Schmitz, for the French Lymphoma Study Association (LYSA), the Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), and the German Lymphoma Alliance (GLA)

MARC

LEADER 00000naa a2200000 c 4500
001 1936105322
003 DE-627
005 20250917085121.0
007 cr uuu---uuuuu
008 250917s2024 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.24.00554  |2 doi 
035 |a (DE-627)1936105322 
035 |a (DE-599)KXP1936105322 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Tournilhac, Olivier  |e VerfasserIn  |0 (DE-588)137665508X  |0 (DE-627)1936105845  |4 aut 
245 1 0 |a Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)  |c Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Guillaume Cartron, Pascal Turlure, Peter Reimer, Eva Wagner-Drouet, Laurence Sanhes, Roch Houot, Murielle Roussel, Frank Kroschinsky, Peter Dreger, Andreas Viardot, Laurence de Leval, Andreas Rosenwald, Philippe Gaulard, Gerald Wulf, Alban Villate, Christelle Latiere, Ahmet Elmaagacli, Bertram Glass, Viola Poeschel, Gandhi Damaj, David Sibon, Eric Durot, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Ulrich Keller, Mourad Tiab, Bernard Drenou, Jérome Cornillon, Stéphanie Nguyen, Marie Robin, Maike Nickelsen, Lorenz Trümper, Georg Lenz, Marita Ziepert, and Norbert Schmitz, for the French Lymphoma Study Association (LYSA), the Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), and the German Lymphoma Alliance (GLA) 
264 1 |c [2024] 
300 |b Diagramme 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 13. September 2024 
500 |a Gesehen am 17.09.2025 
520 |a Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. - Primary analysis of the phase III randomized AATT study showed that younger patients with peripheral T-cell lymphoma (PTCL) consolidated with autologous or allogeneic transplantation (alloSCT) had similar event-free survival (EFS) and overall survival (OS). Seven-year EFS of patients randomly assigned to alloSCT was 38% (95% CI, 25 to 52) compared with 34% (95% CI, 22 to 47) for patients randomly assigned to autologous transplantation of hematopoietic stem cells (autoSCT); OS was 55% (95% CI, 41 to 69) and 61% (95% CI, 47 to 74). Among patients undergoing alloSCT (n = 26) or autoSCT (n = 41) on study, the cumulative progression/relapse rate was 8% (95% CI, 0 to 19) and 55% (95% CI, 35 to 74). Nonrelapse mortality (NRM) was 31% (95% CI, 13 to 49) and 3% (95% CI, 0 to 8) after alloSCT and autoSCT, respectively. Fifteen of 30 patients with early progression and 11 of 20 patients with progression/relapse after autoSCT received alloSCT. Seven-year OS after salvage alloSCT was 61% (95% CI, 47 to 74); NRM was 23% (95% CI, 6 to 40). Long-term follow-up documents the strong graft versus lymphoma effect of alloSCT independent of the timing of transplantation. Survival of patients unable to undergo transplantation was dismal. AlloSCT is the treatment of choice for younger, transplant-eligible patients with relapsed/refractory PTCL. AlloSCT is currently not recommended as part of first-line consolidation. 
700 1 |a Altmann, Bettina  |e VerfasserIn  |4 aut 
700 1 |a Friedrichs, Birte  |e VerfasserIn  |4 aut 
700 1 |a Bouabdallah, Kamal  |e VerfasserIn  |4 aut 
700 1 |a Leclerc, Mathieu  |e VerfasserIn  |4 aut 
700 1 |a Cartron, Guillaume  |e VerfasserIn  |4 aut 
700 1 |a Turlure, Pascal  |e VerfasserIn  |4 aut 
700 1 |a Reimer, Peter  |e VerfasserIn  |4 aut 
700 1 |a Wagner-Drouet, Eva  |e VerfasserIn  |4 aut 
700 1 |a Sanhes, Laurence  |e VerfasserIn  |4 aut 
700 1 |a Houot, Roch  |e VerfasserIn  |4 aut 
700 1 |a Roussel, Murielle  |e VerfasserIn  |4 aut 
700 1 |a Kroschinsky, Frank  |e VerfasserIn  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
700 1 |a Viardot, Andreas  |e VerfasserIn  |4 aut 
700 1 |a de Leval, Laurence  |e VerfasserIn  |4 aut 
700 1 |a Rosenwald, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Gaulard, Philippe  |e VerfasserIn  |4 aut 
700 1 |a Wulf, Gerald  |e VerfasserIn  |4 aut 
700 1 |a Villate, Alban  |e VerfasserIn  |4 aut 
700 1 |a Latiere, Christelle  |e VerfasserIn  |4 aut 
700 1 |a Elmaagacli, Ahmet  |e VerfasserIn  |4 aut 
700 1 |a Glass, Bertram  |e VerfasserIn  |4 aut 
700 1 |a Poeschel, Viola  |e VerfasserIn  |4 aut 
700 1 |a Damaj, Gandhi  |e VerfasserIn  |4 aut 
700 1 |a Sibon, David  |e VerfasserIn  |4 aut 
700 1 |a Durot, Eric  |e VerfasserIn  |4 aut 
700 1 |a Bilger, Karin  |e VerfasserIn  |4 aut 
700 1 |a Banos, Anne  |e VerfasserIn  |4 aut 
700 1 |a Haenel, Mathias  |e VerfasserIn  |4 aut 
700 1 |a Dreyling, Martin  |e VerfasserIn  |4 aut 
700 1 |a Keller, Ulrich  |e VerfasserIn  |4 aut 
700 1 |a Tiab, Mourad  |e VerfasserIn  |4 aut 
700 1 |a Drenou, Bernard  |e VerfasserIn  |4 aut 
700 1 |a Cornillon, Jérome  |e VerfasserIn  |4 aut 
700 1 |a Nguyen, Stéphanie  |e VerfasserIn  |4 aut 
700 1 |a Robin, Marie  |e VerfasserIn  |4 aut 
700 1 |a Nickelsen, Maike  |e VerfasserIn  |4 aut 
700 1 |a Trümper, Lorenz  |e VerfasserIn  |4 aut 
700 1 |a Lenz, Georg  |e VerfasserIn  |4 aut 
700 1 |a Ziepert, Marita  |e VerfasserIn  |4 aut 
700 1 |a Schmitz, Norbert  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 42(2024), 32, Seite 3788-3794  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma) 
773 1 8 |g volume:42  |g year:2024  |g number:32  |g pages:3788-3794  |g extent:7  |a Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma) 
856 4 0 |u https://doi.org/10.1200/JCO.24.00554  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ascopubs.org/doi/10.1200/JCO.24.00554  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250917 
993 |a Article 
994 |a 2024 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 14 
999 |a KXP-PPN1936105322  |e 4772853812 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"[2024]"}],"recId":"1936105322","relHost":[{"origin":[{"dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}],"recId":"313116962","type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"disp":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)Journal of clinical oncology","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1527-7755"],"zdb":["2005181-5"],"eki":["313116962"]},"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"title":[{"title":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology"}],"language":["eng"],"part":{"year":"2024","text":"42(2024), 32, Seite 3788-3794","volume":"42","issue":"32","extent":"7","pages":"3788-3794"},"pubHistory":["1.1983 -"]}],"note":["Online veröffentlicht: 13. September 2024","Gesehen am 17.09.2025"],"id":{"eki":["1936105322"],"doi":["10.1200/JCO.24.00554"]},"physDesc":[{"noteIll":"Diagramme","extent":"7 S."}],"name":{"displayForm":["Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Guillaume Cartron, Pascal Turlure, Peter Reimer, Eva Wagner-Drouet, Laurence Sanhes, Roch Houot, Murielle Roussel, Frank Kroschinsky, Peter Dreger, Andreas Viardot, Laurence de Leval, Andreas Rosenwald, Philippe Gaulard, Gerald Wulf, Alban Villate, Christelle Latiere, Ahmet Elmaagacli, Bertram Glass, Viola Poeschel, Gandhi Damaj, David Sibon, Eric Durot, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Ulrich Keller, Mourad Tiab, Bernard Drenou, Jérome Cornillon, Stéphanie Nguyen, Marie Robin, Maike Nickelsen, Lorenz Trümper, Georg Lenz, Marita Ziepert, and Norbert Schmitz, for the French Lymphoma Study Association (LYSA), the Société Francophone de greffe de moelle et Thérapie Cellulaire (SFGM-TC), and the German Lymphoma Alliance (GLA)"]},"person":[{"given":"Olivier","role":"aut","display":"Tournilhac, Olivier","family":"Tournilhac"},{"role":"aut","given":"Bettina","display":"Altmann, Bettina","family":"Altmann"},{"display":"Friedrichs, Birte","given":"Birte","role":"aut","family":"Friedrichs"},{"display":"Bouabdallah, Kamal","role":"aut","given":"Kamal","family":"Bouabdallah"},{"family":"Leclerc","given":"Mathieu","role":"aut","display":"Leclerc, Mathieu"},{"family":"Cartron","display":"Cartron, Guillaume","role":"aut","given":"Guillaume"},{"family":"Turlure","given":"Pascal","role":"aut","display":"Turlure, Pascal"},{"family":"Reimer","display":"Reimer, Peter","given":"Peter","role":"aut"},{"family":"Wagner-Drouet","given":"Eva","role":"aut","display":"Wagner-Drouet, Eva"},{"family":"Sanhes","display":"Sanhes, Laurence","given":"Laurence","role":"aut"},{"display":"Houot, Roch","role":"aut","given":"Roch","family":"Houot"},{"family":"Roussel","display":"Roussel, Murielle","given":"Murielle","role":"aut"},{"given":"Frank","role":"aut","display":"Kroschinsky, Frank","family":"Kroschinsky"},{"display":"Dreger, Peter","role":"aut","given":"Peter","family":"Dreger"},{"family":"Viardot","display":"Viardot, Andreas","role":"aut","given":"Andreas"},{"role":"aut","given":"Laurence","display":"de Leval, Laurence","family":"de Leval"},{"given":"Andreas","role":"aut","display":"Rosenwald, Andreas","family":"Rosenwald"},{"family":"Gaulard","display":"Gaulard, Philippe","given":"Philippe","role":"aut"},{"given":"Gerald","role":"aut","display":"Wulf, Gerald","family":"Wulf"},{"family":"Villate","display":"Villate, Alban","given":"Alban","role":"aut"},{"family":"Latiere","display":"Latiere, Christelle","given":"Christelle","role":"aut"},{"display":"Elmaagacli, Ahmet","role":"aut","given":"Ahmet","family":"Elmaagacli"},{"given":"Bertram","role":"aut","display":"Glass, Bertram","family":"Glass"},{"given":"Viola","role":"aut","display":"Poeschel, Viola","family":"Poeschel"},{"family":"Damaj","role":"aut","given":"Gandhi","display":"Damaj, Gandhi"},{"display":"Sibon, David","role":"aut","given":"David","family":"Sibon"},{"role":"aut","given":"Eric","display":"Durot, Eric","family":"Durot"},{"family":"Bilger","display":"Bilger, Karin","role":"aut","given":"Karin"},{"display":"Banos, Anne","role":"aut","given":"Anne","family":"Banos"},{"family":"Haenel","display":"Haenel, Mathias","role":"aut","given":"Mathias"},{"given":"Martin","role":"aut","display":"Dreyling, Martin","family":"Dreyling"},{"family":"Keller","display":"Keller, Ulrich","given":"Ulrich","role":"aut"},{"family":"Tiab","role":"aut","given":"Mourad","display":"Tiab, Mourad"},{"role":"aut","given":"Bernard","display":"Drenou, Bernard","family":"Drenou"},{"given":"Jérome","role":"aut","display":"Cornillon, Jérome","family":"Cornillon"},{"family":"Nguyen","display":"Nguyen, Stéphanie","given":"Stéphanie","role":"aut"},{"family":"Robin","display":"Robin, Marie","role":"aut","given":"Marie"},{"family":"Nickelsen","display":"Nickelsen, Maike","role":"aut","given":"Maike"},{"role":"aut","given":"Lorenz","display":"Trümper, Lorenz","family":"Trümper"},{"family":"Lenz","role":"aut","given":"Georg","display":"Lenz, Georg"},{"family":"Ziepert","display":"Ziepert, Marita","role":"aut","given":"Marita"},{"family":"Schmitz","given":"Norbert","role":"aut","display":"Schmitz, Norbert"}],"language":["eng"],"title":[{"title_sort":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)","title":"Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)"}]} 
SRT |a TOURNILHACLONGTERMFO2024